Universiti Tunku Abdul Rahman   Report issue

Academic/Hospital Phase 2
Founded: Kampar Malaysia (2002)

Organization Overview

First Clinical Trial
2019
NCT03847844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alumnus of Universiti Tunku Abdul Rahman | Universiti Tunku Abdul Rahman | Universiti Tunku Abdul Rahman (UTAR)

Active Ingredients

Drugs in Phase 2 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Graft vs Host Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1